Research Grade
Reactivity: Human
FACS
Host: Humanized
Monoclonal
unconjugated
Restrictions
For Research Use only
Buffer
PBS pH 7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target
MS4A1 (Obinutuzumab Biosimilar)
Target Type
Biosimilar
Background
GA101,RG7159,RO5072759,afutuzumab Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML).